Epitel’s REMI system and REMI Vigilenz AI receive FDA 510(k) clearance
Epitel has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its REMI Remote EEG Monitoring System for Ambulatory (at home) use and REMI Vigilenz AI For Event Detection.
